Sequential Two-agent Assessment in Renal Cell Carcinoma Therapy: The START Trial
Clinical trial NCT01217931 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT01217931
- Sponsor
- M.D. Anderson Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-19
- Primary completion
- 2028-01-31
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.